Baseline characteristics of patients attaining CR with cyclophosphamide
| Age at Dx . | Sex . | Rheumatologic disease . | Prior Tx . | Cy line . | Cy indication . | Max Cy dose . | Time on Cy, mo . | Time before CR after starting Cy, mo . | Did patient have CMR (time to CMR, M)? . |
|---|---|---|---|---|---|---|---|---|---|
| 66 | F | RA | CsA (×2), MTX | 4th | Neutropenia | 50 mg BID | 11 | 12 | No |
| 66 | M | None | MTX | 2nd | Anemia | 50 mg BID | 10 | 5.5 | No |
| 70 | F | RA | MTX | 2nd | Anemia | 50 mg daily | 12 | 5 | Yes (7 mo) |
| 67 | F | None | MTX (×2) | 3rd | Anemia and Neutropenia | 100 mg daily | 13 | 4 | Yes (12 mo) |
| 66 | M | None | MTX, BNZ-1 | 3rd | Neutropenia | 100 mg daily | 15 | 5 | Yes (11 mo) |
| 65 | M | RA | MTX | 2nd | Neutropenia | 50 mg BID | 11 | 3 | No |
| Age at Dx . | Sex . | Rheumatologic disease . | Prior Tx . | Cy line . | Cy indication . | Max Cy dose . | Time on Cy, mo . | Time before CR after starting Cy, mo . | Did patient have CMR (time to CMR, M)? . |
|---|---|---|---|---|---|---|---|---|---|
| 66 | F | RA | CsA (×2), MTX | 4th | Neutropenia | 50 mg BID | 11 | 12 | No |
| 66 | M | None | MTX | 2nd | Anemia | 50 mg BID | 10 | 5.5 | No |
| 70 | F | RA | MTX | 2nd | Anemia | 50 mg daily | 12 | 5 | Yes (7 mo) |
| 67 | F | None | MTX (×2) | 3rd | Anemia and Neutropenia | 100 mg daily | 13 | 4 | Yes (12 mo) |
| 66 | M | None | MTX, BNZ-1 | 3rd | Neutropenia | 100 mg daily | 15 | 5 | Yes (11 mo) |
| 65 | M | RA | MTX | 2nd | Neutropenia | 50 mg BID | 11 | 3 | No |
BID, twice daily; CsA, cyclosporine; Dx, diagnosis; MTX, methotrexate; RA, rheumatoid arthritis; Tx, treatment.